first-line targeted therapy in mrcc
Published 6 years ago • 46 plays • Length 4:14Download video MP4
Download video MP3
Similar videos
-
2:03
first-line therapy options in mrcc
-
5:00
evolution of targeted therapy in mrcc
-
5:55
first-line kidney cancer treatment: targeted therapy
-
1:51
nicolas salgia, bsc, on ways ethnicity impacts 1st line mrcc patients receiving targeted therapy
-
1:33
discontinuing vegf-targeted therapy for progression affects second-line therapies in mrcc
-
2:11
second-line toxicities after first-line tki in mrcc
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
4:24
evolution of combination therapy in nccrcc, papillary subtype
-
20:11
cytoreductive surgery in the era of targeted therapy for kidney cancer
-
1:06
dr. toni choueiri on nivolumab and cabozantinib becoming first-line therapies in rcc
-
9:24
distinct cytokines predict response to immunotherapy and targeted therapy in mrcc
-
3:13
approaches to second-line therapy in mrcc
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
5:02
new therapy options in newly diagnosed mrcc
-
59:55
renal cell carcinoma: past, present, and future
-
8:03
progress in first-line mrcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
2:02
cabozantinib in mrcc